Given that length of time and number of trial participants are a result of anticipated clinical effect rather than trial Phase categorization -- which this guy must know -- he seems to be in the denial phase.
MayoMobile's article linked in responses to AlzheimersReseachUK's biased post. AlzheimersResearchUK Post Not surprised all these organizations are protecting their decades old Amyloid theory. Great job on the article Mayo! Thanks for educating everyone.
You have all you need to allow and approve a drug for a death sentences population
Unless of course you don’t want to stop diseased people from becoming mentally invalid and dying, then of course you need more people for a longer trial.. so more people may die.